Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiology of Tourette syndrome.

Literature DB >> 9115469

Epidemiology of Tourette syndrome.

Abstract

The epidemiology of Tourette syndrome is difficult to characterize because there is no definitive diagnosis. Symptom intensity and frequency decrease with age and in social situations, and affected individuals are often unaware of their tics. This chapter reviews and summarizes current data on the prevalence, distribution, and risk factors for Tourette syndrome.

Entities: Disease

Mesh：

Year: 1997 PMID： 9115469 DOI： 10.1016/s0733-8619(05)70320-0

Source DB: PubMed Journal: Neurol Clin ISSN： 0733-8619 Impact factor: 3.806

Keyword Cloud
Cited

14 in total

1. Immediate and long term outcome after infrathalamic and thalamic lesioning for intractable Tourette's syndrome.

Authors: T B Babel; P C Warnke; C B Ostertag
Journal: J Neurol Neurosurg Psychiatry Date: 2001-05 Impact factor: 10.154

2. Methylphenidate role in Tourette syndrome prevalence.

Authors: J G Millichap
Journal: J R Soc Med Date: 1999-03 Impact factor: 5.344

3. Epidemiological survey of Tourette syndrome in children and adolescents in Wenzhou of P.R. China.

Authors: Rong Jin; Rong-yuan Zheng; Wen-wu Huang; Hui-qin Xu; Bei Shao; Hong Chen; Liang Feng
Journal: Eur J Epidemiol Date: 2005 Impact factor: 8.082

4. Adult onset tic disorders.

Authors: S Chouinard; B Ford
Journal: J Neurol Neurosurg Psychiatry Date: 2000-06 Impact factor: 10.154

5. Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.

Authors: Paola Devoto; Roberto Frau; Valentina Bini; Giuliano Pillolla; Pierluigi Saba; Giovanna Flore; Marta Corona; Francesco Marrosu; Marco Bortolato
Journal: Psychoneuroendocrinology Date: 2011-10-24 Impact factor: 4.905

10. Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols.

Authors: Ahmad Seif Kanaan; Ewgeni Jakubovski; Kirsten Müller-Vahl
Journal: Brain Sci Date: 2017-04-26

Epidemiology of Tourette syndrome.

1. Immediate and long term outcome after infrathalamic and thalamic lesioning for intractable Tourette's syndrome.

2. Methylphenidate role in Tourette syndrome prevalence.

3. Epidemiological survey of Tourette syndrome in children and adolescents in Wenzhou of P.R. China.

4. Adult onset tic disorders.

5. Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.

Review 6. Pharmacological options for the treatment of Tourette's disorder.

7. Association between intracellular infectious agents and Tourette's syndrome.

Review 8. Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches.

9. Case report on Tourette syndrome treated successfully with aripiprazole.

10. Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols.